QGEN Qiagen N.V.
Healthcare$35.54+1.05%ClosedMarket Cap: $7.32B
As of 2026-05-26
Valuation
P/E (TTM)
19.46
PEG
0.05
P/B
2.19
P/S
3.45
EV/EBITDA
11.87
DCF Value
$69.81
FCF Yield
5.7%
Div Yield
0.7%
Margins & Returns
Gross Margin
61.6%
Operating Margin
24.9%
Net Margin
19.2%
ROE
11.3%
ROA
7.0%
ROIC
8.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $492.3M | 62.9% | $116.6M | $68.0M | $— | $2.41 |
| Q4 null | $540.4M | 58.7% | $153.9M | $107.8M | $— | — |
| FY null | $2.09B | 61.8% | $520.3M | $424.9M | $— | $1.51 |
| Q3 null | $532.6M | 62.2% | $129.2M | $130.0M | $— | $0.25 |
| Q2 null | $533.5M | 62.7% | $121.9M | $96.3M | $— | — |
| Q1 null | $483.5M | 63.8% | $115.3M | $90.8M | $— | $1.26 |
| Q4 null | $521.2M | 63.9% | $119.1M | $88.3M | $— | — |
| FY null | $1.98B | 48.9% | $97.7M | $83.6M | $— | $1.28 |
| Q3 null | $501.9M | 61.4% | $112.1M | $98.1M | $— | — |
| Q2 null | $496.3M | 7.0% | $-228.4M | $-183.5M | $— | — |
| Q1 null | $458.8M | 63.4% | $94.9M | $80.7M | $— | $1.28 |
| Q4 2023 | $509.2M | 62.1% | $110.6M | $97.7M | $0.44 | — |